miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features
- 1 March 2019
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 79 (5), 941-953
- https://doi.org/10.1158/0008-5472.can-18-1675
Abstract
Various cancer stem cell (CSC) biomarkers have been identified for hepatocellular carcinoma (HCC), but little is known about the implications of heterogeneity and shared molecular networks within the CSC population. Through miRNA profile analysis in a HCC cohort (n=241) for five groups of CSC+ HCC tissues, i.e., EpCAM+, CD90+, CD133+, CD44+, and CD24+ HCC,we identified a 14-miRNA signature commonly altered among these five groups of CSC+ HCC. MiR-192-5p, the top ranked CSC-miRNA, was liver -abundant and -specific and markedly downregulated in all five groups of CSC+ HCC from two independent cohorts (n=613). Suppressing miR-192-5p in HCC cells significantly increased multiple CSC populations and CSC-related features through targeting PABPC4. Both TP53 mutation and hyper-methylation of the mir-192 promoter impeded transcriptional activation of miR-192-5p in HCC cell lines and primary CSC+ HCC. This study reveals the circuit from hyper-methylation of the mir-192 promoter through the increase in PABPC4 as a shared genetic regulatory pathway in various groups of primary CSC+ HCC. This circuit may be the driver that steers liver cells toward hepatic CSC cells, leading to hepatic carcinogenesis.Keywords
Other Versions
Funding Information
- National Natural Science Foundation of China (81672905 and 81874054)
- NCI (P30-CA071789)
This publication has 52 references indexed in Scilit:
- Integrative Genomic Identification of Genes on 8p Associated With Hepatocellular Carcinoma Progression and Patient SurvivalGastroenterology, 2012
- Association of TP53 Mutations With Stem Cell-Like Gene Expression and Survival of Patients With Hepatocellular CarcinomaGastroenterology, 2011
- RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentCancer Cell, 2010
- Let-7g targets collagen type I α2 and inhibits cell migration in hepatocellular carcinomaJournal of Hepatology, 2010
- MicroRNA Expression, Survival, and Response to Interferon in Liver CancerNew England Journal of Medicine, 2009
- Cancer stem cells: mirage or reality?Nature Medicine, 2009
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cellsHepatology, 2009
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell FeaturesGastroenterology, 2009
- What’s Driving False Discovery Rates?Journal of Proteome Research, 2007